Esperion Therapeutics
ESPR
#7603
Rank
S$0.40 B
Marketcap
$2.03
Share price
1.34%
Change (1 day)
-30.44%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$3.85

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.76. In 2022 the company made an earnings per share (EPS) of -$4.74 an increase over its 2021 EPS that were of -$12.76.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.85-18.73%
2022-$4.74-62.87%
2021-$12.7680.38%
2020-$7.0750.14%
2019-$4.71-53.18%
2018-$10.067.41%
2017-$9.37110.81%
2016-$4.4447.35%
2015-$3.020.89%
2014-$2.9928.84%
2013-$2.32-89.3%
2012-$21.69
2002-$9.148.89%
2001-$8.39-83.77%
2000-$51.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$13.67 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.04-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.48-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$49.87-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.85-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.91-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA